Findlay Park Partners’s ICU Medical ICUI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-655,299
Closed -$135M 51
2021
Q2
$135M Sell
655,299
-15,837
-2% -$3.26M 0.92% 36
2021
Q1
$138M Buy
671,136
+142,311
+27% +$30.1M 0.96% 35
2020
Q4
$113M Buy
528,825
+78,825
+18% +$15.3M 0.79% 39
2020
Q3
$82.2M Hold
450,000
0.57% 41
2020
Q2
$82.9M Hold
450,000
0.65% 41
2020
Q1
$90.8M Hold
450,000
0.87% 33
2019
Q4
$84.2M Hold
450,000
0.66% 40
2019
Q3
$71.8M Buy
450,000
+150,000
+50% +$29.9M 0.63% 41
2019
Q2
$75.6M Buy
+300,000
New +$69.5M 0.67% 38

Other funds holding ICUI

Findlay Park Partners's ICUI Position: Q3 2021 in Review

Findlay Park Partners sold out of ICU Medical (ICUI) in Q3 2021, closing a stake of 655,299 shares — an estimated $135M sold.

Findlay Park Partners first reported a position in ICUI in Q2 2019 and held it in 9 quarters. The position peaked at $138M in Q1 2021. 276 funds tracked by Wall St. Rank hold ICUI as of Q3 2021.

  • Findlay Park Partners reported no remaining ICU Medical position as of Q3 2021 after selling out during the quarter.
  • Findlay Park Partners sold 655,299 ICU Medical shares in Q3 2021, an estimated $135M.
  • Findlay Park Partners first reported a position in ICU Medical in Q2 2019 and held it in 9 quarters.
  • Findlay Park Partners's ICU Medical position peaked at $138M in Q1 2021.
  • 276 funds tracked by Wall St. Rank held ICU Medical as of Q3 2021.

Based on Findlay Park Partners's 13F filing for Q3 2021, filed 12 Nov 2021.